Pluri (NASDAQ: PLUR) curbs share sale capacity to $290K

Rhea-AI Filing Summary

Pluri Inc. (PLUR) updated its at-the-market equity program, conducted through A.G.P./Alliance Global Partners as sales agent, to reduce the maximum aggregate amount of common shares that may be offered under its Sales Agreement. The overall program size is decreased from $10,000,000 to $290,000 as of August 26, 2026. From the start of the program to this date, Pluri has already sold $990,344 of common shares under the Sales Agreement. Under this updated prospectus supplement, Pluri may now offer and sell additional common shares with a maximum aggregate offering price of $290,000 from time to time through A.G.P. as sales agent or principal. The common shares trade on Nasdaq under the symbol PLUR, and the last reported sale price on August 26, 2026 was $1.48 per share.

Filing Explained

The filing authorizes future capacity, not a completed sale; dilution depends on whether shares are later issued.

The supplement changes the ATM Program authorization as of August 26, 2026, but does not report a completed sale under the revised amount.

An ATM program permits gradual sales into the market. If Pluri later issues shares, the total share count would rise and existing holders’ percentage ownership would fall; that effect is conditional on issuance.

The $290,000 is a ceiling on future offering price, not committed proceeds or proceeds already received. The latest reported quarter showed $3,419,000 of cash and equivalents and $4,512,000 of operating cash use.

The material watch item is a later filing or Sales Agreement report showing whether Pluri uses the remaining ATM capacity and how many shares are issued.

Key Figures

Reduced ATM Program Size: $290,000 maximum aggregate offering price Original ATM Program Size: $10,000,000 maximum aggregate offering price Common Shares Sold Under Sales Agreement: $990,344 aggregate offering price +5 more

8 metrics

Reduced ATM Program Size $290,000 maximum aggregate offering price Maximum common share offering amount under Sales Agreement after reduction as of August 26, 2026

Original ATM Program Size $10,000,000 maximum aggregate offering price Initial maximum common share amount that could be offered under the Sales Agreement

Common Shares Sold Under Sales Agreement $990,344 aggregate offering price Total common shares offered and sold from the date of the ATM prospectus to this supplement

Last Reported Share Price $1.48 per share Nasdaq last reported sale price of common shares on August 26, 2026

Non-Affiliate Market Value $15,212,465 Aggregate market value of common shares held by non-affiliates under Form S-3 I.B.6

Non-Affiliate Shares Count 6,978,195 shares Number of common shares held by non-affiliates used in I.B.6 calculation

Price Used for I.B.6 Calculation $2.18 per share Closing price on July 6, 2026 applied to non-affiliate shares for market value

Securities Sold Under I.B.6 in Prior 12 Months $736,846 Amount of securities offered or sold pursuant to Form S-3 General Instruction I.B.6 in the prior 12-month period

Key Terms

at-the-market offering, Sales Agreement, General Instruction I.B.6 of Form S-3, prospectus supplement

4 terms

at-the-market offering financial

"as our sales agent for an “at-the-market offering” program, or ATM Program"

An at-the-market offering is a method companies use to sell new shares of stock directly into the open market over time, rather than all at once. This allows them to raise money gradually, similar to selling small pieces of a product instead of a large batch. For investors, it means the company can access funding more flexibly, but it may also increase the supply of shares and influence the stock’s price.

Sales Agreement financial

"In accordance with the terms of the Sales Agreement, dated February 13, 2024"

A sales agreement is a written contract that sets out the terms for selling goods, services, or assets, specifying price, delivery, payment schedule and responsibilities of each side. For investors it matters because it creates a predictable stream of revenue or cash obligations, clarifies timing and risk, and can change a company’s value or forecasts much like a signed order turns a customer’s verbal intent into a firm commitment.

General Instruction I.B.6 of Form S-3 regulatory

"The aggregate market value of our Common Shares held by non-affiliates pursuant to General Instruction I.B.6"

prospectus supplement regulatory

"This prospectus supplement should be read in conjunction with the ATM Prospectus"

A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.

Offering Details

shelf/ATM

Offering

Offering Type shelf/ATM

FAQ

What change to the ATM program does Pluri Inc. (PLUR) disclose in this 424B3?

Pluri Inc. reduced the maximum aggregate offering price of common shares under its at-the-market program from $10,000,000 to $290,000 as of August 26, 2026, while continuing to sell shares through A.G.P./Alliance Global Partners as sales agent or principal.

How much can Pluri Inc. (PLUR) still sell under the updated ATM program?

Under the updated prospectus supplement, Pluri Inc. may offer and sell additional common shares with a maximum aggregate offering price of up to $290,000 from time to time through A.G.P./Alliance Global Partners, acting as sales agent or principal under the Sales Agreement.

How much has Pluri Inc. (PLUR) already sold under the Sales Agreement?

From the date of the original ATM prospectus to this prospectus supplement, Pluri Inc. has offered and sold $990,344 of its common shares under the Sales Agreement with A.G.P./Alliance Global Partners.

What is the recent Nasdaq trading price of Pluri Inc. (PLUR) common shares mentioned here?

On August 26, 2026, the last reported sale price of Pluri Inc.’s common shares on Nasdaq was $1.48 per share. This price is provided as market context for the at-the-market offering program.

What is the aggregate market value of Pluri Inc. (PLUR) non-affiliate shares used for Form S-3 I.B.6?

The aggregate market value of Pluri Inc.’s common shares held by non-affiliates is stated as $15,212,465, based on 6,978,195 shares held by non-affiliates at a price of $2.18 per share, the closing price on July 6, 2026.

How much has Pluri Inc. (PLUR) sold under Form S-3 General Instruction I.B.6 in the last 12 months?

Pluri Inc. states that, as of this prospectus supplement, it has offered or sold $736,846 of its securities pursuant to General Instruction I.B.6 of Form S-3 during the prior 12 calendar month period ending on the date of the supplement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/27/2026 - 06:10 AM Accepted by SEC EDGAR 08/26/2026 - 09:54 PM Learn about SEC filing dates

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-273347

PROSPECTUS SUPPLEMENT NO. 1 TO PROSPECTUS SUPPLEMENT DATED FEBRUARY 13, 2024

(to Prospectus dated September 21, 2023)

Up to $290,000

Common Shares

This prospectus supplement updates and amends certain information contained in the prospectus supplement, dated February 13, 2024, which supplemented the accompanying prospectus dated September 21, 2023, or, together, the ATM Prospectus, relating to the offer and sale of shares of our common shares, or the Common Shares, through A.G.P./Alliance Global Partners, or A.G.P., as our sales agent for an “at-the-market offering” program, or ATM Program. In accordance with the terms of the Sales Agreement, dated February 13, 2024, or the Sales Agreement, we may offer and sell up to a maximum of $10,000,000 of our Common Shares from time to time through A.G.P. as our sales agent. Of this amount, as of August 26, 2026, $9,009,656 remains available for issuance under the ATM Program. This prospectus supplement should be read in conjunction with the ATM Prospectus, and is qualified by reference to the ATM Prospectus, except to the extent that the information presented herein supersedes the information contained in the ATM Prospectus. This prospectus supplement is not complete without, and may only be delivered or utilized in connection with, the ATM Prospectus, including any amendments or supplements thereto.

We are filing this prospectus supplement to supplement and amend, as of August 26, 2026, the ATM Prospectus to decrease the maximum aggregate offering price of our Common Shares that may be offered, issued and sold under the Sales Agreement from $10,000,000 to $290,000. From the date of the ATM Prospectus to the date of this prospectus supplement, we have offered and sold $990,344 of our Common Shares under the Sales Agreement. Accordingly, under this prospectus supplement, we may offer and sell Common Shares having a maximum aggregate offering price of up to $290,000 from time to time through A.G.P. acting as our sales agent or principal in accordance with the Sales Agreement.

Our Common Shares are listed on The Nasdaq Stock Market, or Nasdaq, under the symbol “PLUR.” On August 26, 2026, the last reported sale price of our Common Shares on Nasdaq was $1.48 per share. The aggregate market value of our Common Shares held by non-affiliates pursuant to General Instruction I.B.6 of Form S-3 is $15,212,465, which was calculated based on 6,978,195 shares outstanding held by non-affiliates and at a price of $2.18 per share, the closing price of our Common Shares on July 6, 2026, a date that is within 60 days of filing this prospectus supplement. As of the date hereof, we have offered or sold $736,846 of our securities pursuant to General Instruction I.B.6 of Form S-3 during the prior 12 calendar month period that ends on and includes the date hereof.

Investing in our Common Shares involves risk. See “Risk Factors” beginning on page S-3 of the ATM Prospectus and in the documents incorporated by reference into the ATM Prospectus for a discussion of information that should be considered in connection with an investment in our Common Shares.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of the ATM Prospectus, this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.

A.G.P.

The date of this prospectus supplement is August 26, 2026